Profound Medical Corp. (PROF)

Name: Profound Medical Corp. (PROF) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

CIK 0001628808 · Nasdaq · Surgical & Medical Instruments & Apparatus

Sector Manufacturing
Fiscal year ends Dec 31

For the year ended 2025-12-31, Profound Medical Corp. reported revenue of $16.10M. Revenue grew 50.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $19.09M.

Key ratios (year ended 2025-12-31)

70.8%

Gross margin

-256.3%

Operating margin

-264.4%

Net margin

-64.1%

Return on year-end equity

50.7%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31
Revenue	$19.09M	$16.10M	$10.68M	$7.20M
Cost of Revenue	$5.38M	$4.71M	$3.64M	$2.89M
Gross Profit	$13.70M	$11.39M	$7.04M	$4.31M
R&D Expense	$20.61M	$20.60M	$16.96M	$14.42M
Operating Income	-$35.37M	-$41.25M	-$33.06M	-$28.65M
Net Income	-$32.74M	-$42.57M	-$27.82M	-$28.32M
EPS (Diluted)	n/a	$1.41	$1.12	$1.34
Total Assets	$62.38M	$77.47M	$70.23M	$43.96M
Total Liabilities	$12.58M	$11.04M	$9.81M	$12.73M
Long-Term Debt	$4.51M	$4.50M	$4.66M	$7.10M
Shareholders' Equity	$49.81M	$66.43M	$60.42M	$31.22M
Cash & Equivalents	$38.27M	$59.72M	$54.91M	$26.21M
Operating Cash Flow	-$36.10M	-$38.21M	-$23.45M	-$22.61M
Capital Expenditures	n/a	$176.0K	n/a	n/a
Free Cash Flow	n/a	-$38.38M	n/a	n/a
Shares Outstanding	36.53M	36.29M	30.04M	21.37M
Weighted Average Diluted Shares	n/a	30.23M	24.77M	21.18M
EPS (Basic)	n/a	$1.41	$1.12	$1.34

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView